August 18, 2025 · Form 4 insider transaction
BONNEY MICHAEL W sold 11,250 shares of Alnylam Pharmaceuticals, Inc. at $450.00 per share, a transaction worth $5.06M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on November 12, 2024.